These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 11818362)
1. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362 [TBL] [Abstract][Full Text] [Related]
2. The role of the fibrinolytic system in corneal angiogenesis. Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500 [TBL] [Abstract][Full Text] [Related]
3. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer. Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
6. The role of fibrinolytic genes and proteins in the development of allograft vascular disease. Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221 [TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821 [TBL] [Abstract][Full Text] [Related]
10. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1. Whitley BR; Church FC Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925 [TBL] [Abstract][Full Text] [Related]
12. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781 [TBL] [Abstract][Full Text] [Related]
13. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor. Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501 [TBL] [Abstract][Full Text] [Related]
14. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor. Leloup G; Lemoine P; Carmeliet P; Vaes G J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251 [TBL] [Abstract][Full Text] [Related]
15. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653 [TBL] [Abstract][Full Text] [Related]
16. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Roca C; Primo L; Valdembri D; Cividalli A; Declerck P; Carmeliet P; Gabriele P; Bussolino F Cancer Res; 2003 Apr; 63(7):1500-7. PubMed ID: 12670896 [TBL] [Abstract][Full Text] [Related]
17. Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice. Almholt K; Nielsen BS; Frandsen TL; Brünner N; Danø K; Johnsen M Oncogene; 2003 Jul; 22(28):4389-97. PubMed ID: 12853975 [TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases. Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701 [TBL] [Abstract][Full Text] [Related]
19. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators and inhibitors are transcribed during early macaque implantation. Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]